Table 6.
Stage, grade, and surgery conditions of patients single at diagnosis in different clinicopathological subgroups (%)
| Variable | Stage | Grade | Surgery | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stage 0/I | Stage II | Stage III | Stage IV | Grade 1 | Grade 2 | Grade 3 | Grade 4 | BCS | Other | No | |||
| Age (years) | Age (years) | Age (years) | |||||||||||
| <35 | 23.25 | 47.59 | 22.07 | 7.1 | <35 | 5.53 | 31.09 | 61.98 | 1.41 | <35 | 35.44 | 57.04 | 7.53 |
| 35‐70 | 38.99 | 38.59 | 16.26 | 6.16 | 35‐70 | 17.08 | 40.77 | 41.06 | 1.09 | 35‐70 | 51.94 | 41.4 | 6.66 |
| ≥70 | 47.04 | 34.17 | 12.38 | 6.42 | ≥70 | 22.7 | 47.19 | 29.2 | 0.91 | ≥70 | 52.65 | 38.87 | 8.47 |
| Race | Race | Race | |||||||||||
| White | 42.08 | 37.37 | 14.88 | 5.67 | White | 19.31 | 43.38 | 36.35 | 0.96 | White | 52.73 | 41.16 | 6.11 |
| Black | 29.92 | 41.43 | 20.29 | 8.36 | Black | 10.65 | 32.97 | 54.95 | 1.43 | Black | 46.74 | 43.26 | 10 |
| AN/AI | 32.9 | 40.39 | 20.2 | 6.51 | AN/AI | 16.94 | 40.07 | 42.35 | 0.65 | AN/AI | 50.81 | 45.6 | 3.58 |
| API | 40.32 | 40.38 | 14.11 | 5.18 | API | 16.7 | 44.03 | 38.02 | 1.25 | API | 48.48 | 45.6 | 5.92 |
| HRs | HRs | HRs | |||||||||||
| ER+/PR+ | 44.27 | 37.03 | 13.56 | 5.15 | ER+/PR+ | 23.05 | 49.89 | 26.48 | 0.58 | ER+/PR+ | 54.79 | 39.53 | 5.68 |
| ER+/PR‐ | 35.34 | 37.02 | 18.87 | 8.77 | ER+/PR‐ | 13.56 | 39.42 | 46.07 | 0.96 | ER+/PR‐ | 46.85 | 44.43 | 8.73 |
| ER‐/PR+ | 26.74 | 46.14 | 20.15 | 6.97 | ER‐/PR+ | 3.77 | 19.96 | 73.82 | 2.45 | ER‐/PR+ | 47.65 | 41.62 | 10.73 |
| ER‐/PR‐ | 26.19 | 44.29 | 22.21 | 7.31 | ER‐/PR‐ | 1.62 | 16.12 | 80 | 2.26 | ER‐/PR‐ | 43.85 | 47.54 | 8.61 |
| Other | 39.37 | 35.25 | 15.31 | 10.07 | Other | 17.96 | 40.44 | 38.91 | 2.7 | Other | 43.49 | 44.81 | 11.7 |
Abbreviations: AN/AI, American Indian/Alaska Native; API, Asian or Pacific Islander; BCS, breast‐conserving surgery; ER, estrogen receptor; HRs, hormone receptor status; PR, progesterone receptor.